An economic evaluation of universal and targeted case-finding strategies for identifying antenatal depression: a model-based analysis comparing common case-finding instruments.

Antenatal depression Case finding Cost-effectiveness

Journal

Archives of women's mental health
ISSN: 1435-1102
Titre abrégé: Arch Womens Ment Health
Pays: Austria
ID NLM: 9815663

Informations de publication

Date de publication:
18 Oct 2023
Historique:
received: 01 05 2023
accepted: 30 09 2023
medline: 18 10 2023
pubmed: 18 10 2023
entrez: 18 10 2023
Statut: aheadofprint

Résumé

Half of women with depression in the perinatal period are not identified in routine care, and missed cases reflect inequalities in other areas of maternity care. Case finding (screening) for depression in pregnant women may be a cost-effective strategy to improve identification, and targeted case finding directs finite resources towards the greatest need. We compared the cost-effectiveness of three case-finding strategies: no case finding, universal (all pregnant women), and targeted (only pregnant women with risk factors for antenatal depression, i.e. history of anxiety/depression, age < 20 years, and adverse life events). A decision tree model was developed to represent case finding (at around 20 weeks gestation) and subsequent treatment for antenatal depression (up to 40 weeks gestation). Costs include case finding and treatment. Health benefits are measured as quality-adjusted life years (QALYs). The sensitivity and specificity of case-finding instruments and prevalence and severity of antenatal depression were estimated from a cohort study of pregnant women. Other model parameters were derived from published literature and expert consultation. The most cost-effective case-finding strategy was a two-stage strategy comprising the Whooley questions followed by the PHQ-9. The mean costs were £52 (universal), £61 (no case finding), and £62 (targeted case finding). Both case-finding strategies improve health compared with no case finding. Universal case finding is cost-saving. Costs associated with targeted case finding are similar to no case finding, with greater health gains, although targeted case finding is not cost-effective compared with universal case finding. Universal case finding for antenatal depression is cost-saving compared to no case finding and more cost-effective than targeted case finding.

Identifiants

pubmed: 37851079
doi: 10.1007/s00737-023-01377-2
pii: 10.1007/s00737-023-01377-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Research for Patient Benefit Programme
ID : NIHR203474

Informations de copyright

© 2023. The Author(s).

Références

Bauer A, Knapp M, Parsonage M (2016) Lifetime costs of perinatal anxiety and depression. J Affect Disord 192:83–90
doi: 10.1016/j.jad.2015.12.005 pubmed: 26707352
Brown JVE, Wilson CA, Ayre K et al (2021) Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD013560.pub2
Brugha T, Bebbington P, Tennant C, Hurry J (1985) The List of Threatening Experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med 15:189–194. https://doi.org/10.1017/S003329170002105X
doi: 10.1017/S003329170002105X pubmed: 3991833
Camacho EM, Shields GE, Eisner E et al (2023) An economic evaluation of targeted case-finding strategies for identifying postnatal depression: a model-based analysis comparing common case-finding instruments. J Affect Disord 334:26–34. https://doi.org/10.1016/j.jad.2023.04.106
Cookson R, Mirelman AJ, Griffin S et al (2017) Using cost-effectiveness analysis to address health equity concerns. Value Health 20:206–212. https://doi.org/10.1016/j.jval.2016.11.027
Cox JL, Holden JM, Sagovsky R (1987) Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression scale. Br J Psychiatry 150:782–786. https://doi.org/10.1192/bjp.150.6.782
doi: 10.1192/bjp.150.6.782 pubmed: 3651732
Cuijpers P, Noma H, Karyotaki E et al (2020) A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry 19:92–107. https://doi.org/10.1002/wps.20701
Cuijpers P, Franco P, Ciharova M, Miguel C, Segre L, Quero S, Karyotaki E (2023) Psychological treatment of perinatal depression: a meta-analysis. Psychol Med 53(6):2596–2608
Dadi AF, Miller ER, Bisetegn TA, Mwanri L (2020) Global burden of antenatal depression and its association with adverse birth outcomes: an umbrella review. BMC Public Health 20:173. https://doi.org/10.1186/s12889-020-8293-9
doi: 10.1186/s12889-020-8293-9 pubmed: 32019560 pmcid: 7001252
Darwin Z, Blower SL, Nekitsing C, Masefield S, Razaq R, Padgett L, Endacott C, Willan K, Dickerson J (2022) Addressing inequalities in the identification and management of perinatal mental health difficulties: the perspectives of minoritised women, healthcare practitioners and the voluntary sector. Frontiers in Global Women’s Health 3:1028192
Dolan P (1997) Modeling valuations for EuroQol health states. Medical Care 35:1095–1108
El-Den S, Pham L, Anderson I et al (2022) Perinatal depression screening: a systematic review of recommendations from member countries of the Organisation for Economic Co-operation and Development (OECD). Arch Womens Ment Health 25:871–893. https://doi.org/10.1007/s00737-022-01249-1
doi: 10.1007/s00737-022-01249-1 pubmed: 35849215 pmcid: 9492701
Heslin M, Jin H, Trevillion K et al (2022) Cost-effectiveness of screening tools for identifying depression in early pregnancy: a decision tree model. BMC Health Serv Res 22:1–17. https://doi.org/10.1186/s12913-022-08115-x
doi: 10.1186/s12913-022-08115-x
Higginbottom GMA, Evans C, Morgan M et al (2019) Experience of and access to maternity care in the UK by immigrant women: a narrative synthesis systematic review. BMJ Open 9:e029478. https://doi.org/10.1136/bmjopen-2019-029478
doi: 10.1136/bmjopen-2019-029478 pubmed: 31892643 pmcid: 6955508
Howard LM, Ryan EG, Trevillion K et al (2018) Accuracy of the Whooley questions and the Edinburgh Postnatal Depression Scale in identifying depression and other mental disorders in early pregnancy. Br J Psychiatry 212:50–56. https://doi.org/10.1192/bjp.2017.9
doi: 10.1192/bjp.2017.9 pubmed: 29433610 pmcid: 6457164
Hutchens BF, Kearney J (2020) Risk factors for postpartum depression: an umbrella review. J Midwifery Women’s Health 65:96–108. https://doi.org/10.1111/jmwh.13067
doi: 10.1111/jmwh.13067
Jones KC, Burns A (2021) Unit costs of health and Social care 2021 Personal Social Services Research Unit (PSSRU). University of Kent, Kent
Kessler D, Bennewith O, Lewis G, Sharp D (2002) Detection of depression and anxiety in primary care: follow up study. BMJ 325:1016–1017. https://doi.org/10.1136/bmj.325.7371.1016
doi: 10.1136/bmj.325.7371.1016 pubmed: 12411363 pmcid: 131021
Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9. J Gen Intern Med 16:606–613
doi: 10.1046/j.1525-1497.2001.016009606.x pubmed: 11556941 pmcid: 1495268
Lee-Carbon L, Nath S, Trevillion K et al (2022) Mental health service use among pregnant and early postpartum women. Soc Psychiatry Psychiatr Epidemiol 57:2229–2240. https://doi.org/10.1007/s00127-022-02331-w
doi: 10.1007/s00127-022-02331-w pubmed: 35902425 pmcid: 9636080
Lewis G, Pelosi AJ, Araya R, Dunn G (1992) Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med 22:465–486. https://doi.org/10.1017/S0033291700030415
doi: 10.1017/S0033291700030415 pubmed: 1615114
Lin P-Z, Xue J-M, Yang B et al (2018) Effectiveness of self-help psychological interventions for treating and preventing postpartum depression: a meta-analysis. Arch Womens Ment Health 21:491–503. https://doi.org/10.1007/s00737-018-0835-0
doi: 10.1007/s00737-018-0835-0 pubmed: 29616334
Littlewood E, Ali S, Ansell P et al (2016) Identification of depression in women during pregnancy and the early postnatal period using the Whooley questions and the Edinburgh Postnatal Depression Scale: protocol for the Born and Bred in Yorkshire: PeriNatal Depression Diagnostic Accuracy (BaBY PaN. BMJ Open 6:e011223
doi: 10.1136/bmjopen-2016-011223 pubmed: 27297012 pmcid: 4916566
Littlewood E, Ali S, Dyson L, Keding A, Ansell P, Bailey D, et al (2018) Identifying perinatal depression with case-finding instruments: a mixed-methods study (BaBY PaNDA – Born and Bred in Yorkshire PeriNatal Depression Diagnostic Accuracy). Health Serv Deliv Res 6(6)
MacLellan J, Collins S, Myatt M et al (2022) Black, Asian and minority ethnic women’s experiences of maternity services in the UK: a qualitative evidence synthesis. J Adv Nurs 78:2175–2190. https://doi.org/10.1111/jan.15233
doi: 10.1111/jan.15233 pubmed: 35332568 pmcid: 9314829
Mavranezouli I, Megnin-Viggars O, Grey N et al (2020) Cost-effectiveness of psychological treatments for post-traumatic stress disorder in adults. PLoS ONE 15:e0232245. https://doi.org/10.1371/journal.pone.0232245
doi: 10.1371/journal.pone.0232245 pubmed: 32353011 pmcid: 7192458
Míguez MC, Vázquez MB (2021) Risk factors for antenatal depression: a review. World J Psychiatry 11:325–336. https://doi.org/10.5498/wjp.v11.i7.325
doi: 10.5498/wjp.v11.i7.325 pubmed: 34327125 pmcid: 8311510
Mitchell AJ, Vaze A, Rao S (2009) Clinical diagnosis of depression in primary care: a meta-analysis. The Lancet 374:609–619. https://doi.org/10.1016/S0140-6736(09)60879-5
doi: 10.1016/S0140-6736(09)60879-5
National Institute of Health and Care Excellence (NICE) (2014) Antenatal and postnatal mental health: clinical management and service guidance (CG 192)
NHS Prescription Services (2021) NHS Electronic Drug Tariff. http://www.drugtariff.nhsbsa.nhs.uk/
NICE (2022) NICE health technology evaluations: the manual. NICE, London
Office for National Statistics (2020) Provisional births in England and Wales: 2020 - number of live births and fertility rates. London
Prady SL, Pickett KE, Gilbody S et al (2016) Variation and ethnic inequalities in treatment of common mental disorders before, during and after pregnancy: combined analysis of routine and research data in the Born in Bradford cohort. BMC Psychiatry 16:1–13. https://doi.org/10.1186/s12888-016-0805-x
doi: 10.1186/s12888-016-0805-x
Shields GE, Wilberforce M, Clarkson P et al (2022) Factors limiting subgroup analysis in cost-effectiveness analysis and a call for transparency. Pharmacoeconomics 40:149–156. https://doi.org/10.1007/s40273-021-01108-4
doi: 10.1007/s40273-021-01108-4 pubmed: 34713422
Slomian J, Honvo G, Emonts P, Reginster JY, Bruyère O (2019) Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes. Womens Health. https://doi.org/10.1177/1745506519844044
The EuroQoL group EQ-5D products (n.d.). http://www.euroqol.org/eq-5d-products.html
Underwood L, Waldie K, D’Souza S et al (2016) A review of longitudinal studies on antenatal and postnatal depression. Arch Womens Ment Health 19:711–720. https://doi.org/10.1007/s00737-016-0629-1
doi: 10.1007/s00737-016-0629-1 pubmed: 27085795
Whooley MA, Avins AL, Miranda J, Browner WS (1997) Case-finding instruments for depression. J Gen Intern Med 12:439–445. https://doi.org/10.1046/j.1525-1497.1997.00076.x
doi: 10.1046/j.1525-1497.1997.00076.x pubmed: 9229283 pmcid: 1497134
Yin X, Sun N, Jiang N et al (2021) Prevalence and associated factors of antenatal depression: Systematic reviews and meta-analyses. Clin Psychol Rev 83:101932. https://doi.org/10.1016/j.cpr.2020.101932
doi: 10.1016/j.cpr.2020.101932 pubmed: 33176244

Auteurs

Elizabeth M Camacho (EM)

School of Health Sciences, University of Manchester, Manchester, UK. elizabeth.camacho@manchester.ac.uk.
Institute of Population Health, University of Liverpool, Liverpool, UK. elizabeth.camacho@manchester.ac.uk.

Gemma E Shields (GE)

School of Health Sciences, University of Manchester, Manchester, UK.

Emily Eisner (E)

School of Health Sciences, University of Manchester, Manchester, UK.
Manchester Mental Health NHS Foundation Trust, Manchester, UK.

Elizabeth Littlewood (E)

Department of Health Sciences, University of York, York, UK.

Kylie Watson (K)

Manchester University NHS Foundation Trust, Manchester, UK.

Carolyn A Chew-Graham (CA)

School of Medicine, Keele University, Keele, UK.

Dean McMillan (D)

Hull York Medical School and Department of Health Sciences, University of York, York, UK.

Shehzad Ali (S)

Hull York Medical School and Department of Health Sciences, University of York, York, UK.
Schulich School of Medicine & Dentistry, Western University, London, Canada.

Simon Gilbody (S)

Hull York Medical School and Department of Health Sciences, University of York, York, UK.

Classifications MeSH